Reports says co-infection with HIV among TB patients more than double previous estimates

Article

WESTPORT, CT (Reuters Health) - UK investigators found that the rate of HIV infection among tuberculosis clinic attendees in London was 11 percent, twice the previously estimated rate. They therefore recommend that HIV testing should be offered to all patients diagnosed with Mycobacterium tuberculosis infection.

Little information is available on HIV and TB co-infection in London and among individuals of different ethnic groups, Dr. Charlotte F.J. Rayner, of St. George's Hospital, London, and colleagues report in the October 28th issue of Lancet. Furthermore, "there is no guidance about when patients with TB should be offered HIV testing or which patients should be tested."

To further investigate, the investigators prospectively collected blood samples by anonymous methods from 202 patients with TB who were attending three London chest clinics between December 1998 and November 1999. They also collected saliva samples from 97 TB contacts and 115 new UK entrants.

"To prevent deductive disclosure," they say, "we collected demographic data on only age group, ethnic origin and sex." The researchers found that 11. 4 percent of the TB patients were HIV-positive. In addition, 5 percent of the individuals screened for TB and 4.3 percent of the new UK entrants were also HIV-positive. They note that the distribution of HIV-positive patients across ethnic groups, age groups and by sex was similar.

"The servoprevalence of HIV-1 in TB patients is more than double previous estimates," Dr. Rayner and his colleagues conclude. "Moreover, because we specifically excluded patients already known to be HIV-positive, the true co-infection rate in South London may be as high as 17 to 20 percent."

Related Videos
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Related Content